Cargando…

An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder

Recent findings have identified salmon calcitonin (sCT), an amylin receptor agonist and analogue of endogenous amylin, as a potential regulator of alcohol-induced activation of the mesolimbic dopamine system and alcohol consumption. Providing that the role of amylin signalling in alcohol-related beh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalafateli, Aimilia Lydia, Vallöf, Daniel, Colombo, Giancarlo, Lorrai, Irene, Maccioni, Paola, Jerlhag, Elisabet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461824/ https://www.ncbi.nlm.nih.gov/pubmed/30710109 http://dx.doi.org/10.1038/s41386-019-0323-x

Ejemplares similares

Activation of amylin receptors attenuates alcohol‐mediated behaviours in rodents
por: Kalafateli, Aimilia Lydia, et al.
Publicado: (2018)

Brain region‐specific neuromedin U signalling regulates alcohol‐related behaviours and food intake in rodents
por: Vallöf, Daniel, et al.
Publicado: (2019)

Effects of sub-chronic amylin receptor activation on alcohol-induced locomotor stimulation and monoamine levels in mice
por: Kalafateli, Aimilia Lydia, et al.
Publicado: (2020)

Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
por: Vallöf, Daniel, et al.
Publicado: (2020)

The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
por: Vallöf, Daniel, et al.
Publicado: (2015)

Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice
por: Aranäs, Cajsa, et al.
Publicado: (2021)

R(+)-Baclofen, but Not S(−)-Baclofen, Alters Alcohol Self-Administration in Alcohol-Preferring Rats
por: Lorrai, Irene, et al.
Publicado: (2016)

Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol‐induced reward in rodents
por: Vallöf, Daniel, et al.
Publicado: (2016)

Insight into the role of the gut-brain axis in alcohol-related responses: Emphasis on GLP-1, amylin, and ghrelin
por: Tufvesson-Alm, Maximilian, et al.
Publicado: (2023)

Animal studies reveal that the ghrelin pathway regulates alcohol-mediated responses
por: Jerlhag, Elisabet
Publicado: (2023)

The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice
por: Vallöf, Daniel, et al.
Publicado: (2016)

Role of inflammation in alcohol-related brain abnormalities: a translational study
por: Lanquetin, Anastasia, et al.
Publicado: (2021)

Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats
por: Aranäs, Cajsa, et al.
Publicado: (2023)

Peripherally Circulating Ghrelin Does Not Mediate Alcohol‐Induced Reward and Alcohol Intake in Rodents
por: Jerlhag, Elisabet, et al.
Publicado: (2014)

The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
por: Egecioglu, Emil, et al.
Publicado: (2013)

Ghrelin Receptor (GHS-R1A) Antagonism Suppresses Both Alcohol Consumption and the Alcohol Deprivation Effect in Rats following Long-Term Voluntary Alcohol Consumption
por: Suchankova, Petra, et al.
Publicado: (2013)

Antismoking agents do not contribute synergistically to semaglutide’s ability to reduce alcohol intake in rats
por: Aranäs, Cajsa, et al.
Publicado: (2023)

The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro
por: Safaeian, Leila, et al.
Publicado: (2020)

The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice
por: Egecioglu, Emil, et al.
Publicado: (2013)

Thermodynamic surprises of Cu(II)–amylin analogue complexes in membrane mimicking solutions
por: Dzień, Emilia, et al.
Publicado: (2022)

Suppressing Effect of Baclofen on Multiple Alcohol-Related Behaviors in Laboratory Animals
por: Colombo, Giancarlo, et al.
Publicado: (2018)

Amylin in the Periphery
por: Wookey, Peter J., et al.
Publicado: (2003)

Amylin Analogues in the Treatment of Diabetes Mellitus: Medicinal Chemistry and Structural Basis of its Function
por: Adeghate, Ernest, et al.
Publicado: (2011)

The Novel Positive Allosteric Modulator of the GABA(B) Receptor, KK-92A, Suppresses Alcohol Self-Administration and Cue-Induced Reinstatement of Alcohol Seeking in Rats
por: Maccioni, Paola, et al.
Publicado: (2021)

Reduction by the Positive Allosteric Modulator of the GABA(B) Receptor, GS39783, of Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats Exposed to the “Sipper” Procedure
por: Maccioni, Paola, et al.
Publicado: (2010)

A Phaseolus vulgaris Extract Reduces Cue-Induced Reinstatement of Chocolate Seeking in Rats
por: Lorrai, Irene, et al.
Publicado: (2016)

The Roles of Amylin in the Periphery
por: Wookey, P. J., et al.
Publicado: (2001)

Predisposition to Alcohol Drinking and Alcohol Consumption Alter Expression of Calcitonin Gene-Related Peptide, Neuropeptide Y, and Microglia in Bed Nucleus of Stria Terminalis in a Subnucleus-Specific Manner
por: Rossetti, Ilaria, et al.
Publicado: (2019)

Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas
por: Bhowmick, Diti Chatterjee, et al.
Publicado: (2022)

Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
por: Kiriyama, Yoshimitsu, et al.
Publicado: (2018)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Novel insights into amylin aggregation
por: Pillay, Karen, et al.
Publicado: (2014)

Monoconjugation of Human Amylin with Methylpolyethyleneglycol
por: Sisnande, Tháyna, et al.
Publicado: (2015)

Calcitonin/Amylin Receptors and Ramps
por: Sexton, Patrick M.
Publicado: (2001)

Amylin as a Neuroendocrine Hormone
por: Young, Andrew A.
Publicado: (2001)

Combined GLP-1 Receptor Agonist and Amylin Analogue Pharmacotherapy to Treat Obesity Comorbid With Type 1 Diabetes
por: Wong, Gunther, et al.
Publicado: (2023)

Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
por: Boyle, Christina Neuner, et al.
Publicado: (2017)

Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk
por: Hoogwerf, Byron J, et al.
Publicado: (2008)

Mediators of Amylin Action in Metabolic Control
por: Boyle, Christina N., et al.
Publicado: (2022)

Amylin as a Future Obesity Treatment
por: Dehestani, Babak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l66o5mlbu73bqq809r0q4g6dmq